|
|
Adamas Pharmaceuticals Inc (ADMS) |
|
|
|
Adamas Pharmaceuticals Inc's Yearly Net Cash Flow Growth 5 Years |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual Net Cash Flow Annual Growth Rates Y/Y▼
|
Annual Net Cash Flow Annual Growth Rates Y/Y▼
|
ADMS Annual Net Cash Flow Growth |
2020
|
2019
|
2018
|
2017
|
2016
|
Y / Y Annual Net Cash Flow Change |
-35.81 % |
- |
- |
- |
- |
Annual Net Cash Flow (in millions $) |
$5.89 |
$9.17 |
$-34.71 |
$67.58 |
$0.00 |
Annual Net Cash Flow Growth
Comment |
Adamas Pharmaceuticals Inc experienced detoriation of Annual Net Cash Flow for the fiscal year ended 2020 by -35.81% to $ 5.89 millions, compare to $ 9.17 in Annual Net Cash Flow reported in the previous year. Adamas Pharmaceuticals Inc's Net Cash Flow decline slowed form -126.42 % contraction in the fiscal year 2019.
Adamas Pharmaceuticals Inc Annual Income Statement
|
You need to upgrade your Flash Player
|
Companies with similar 2020 Annual Net Cash Flow within Healthcare Sector | Y/Y Net Cash Flow Growth % | 2020 Annual Net Cash Flow | Quest Diagnostics Inc | | | |